News & Events
News
June 6, 2022 - From
听
On June 6, 2022, MP Andy Fillmore announced an investment of nearly $1.5M for 3 projects led by researchers in Nova Scotia to understand the wider health impacts of the pandemic on Canadians.听
Janice Graham (Director of TRRU) and her team received $489,566 to engage with social scientists, public health experts, and members of equity-deserving groups to develop recommendations for a more equitable and supportive healthcare governance framework in post-COVID Canada. Shawn Harmon (Co-Investigator) and Ksenia Kholina (Research Fellow) represented TRRU team at the announcement event.听
听
Upcoming Events
No upcoming events at this time听
听
听
听
Past Events
Poster Presentation at Maritime Health Research Summit: "Public Health Governance: Emerging Themes From Community Engagements Across Canada"听
On Thursday October 24th 2024, Technoscience and Regulation Research Unit research in medicine student Brianna Legere, and research assistant Ella Hunter presented on preliminary findings from Phase 2 of the Public Health Governance Project听at the Maritime Health Research Summit.听
Immunization Responses in Canada: A Nation-wide Analysis of Gaps in the "System"
听
On听Wednesday December 8th 2021,听Technoscience and Regulation Research Unit presented a symposium at the Canadian Immunization conference on听Immunization Responses in Canada: A Nation-wide Analysis of Gaps in the "System".听
Scholarship undertaken throughout the pandemic has identified a range of gaps in Canada鈥檚 immunization听governance landscape, some of them persisting despite long-running calls for reform (e.g., absence of patient-centred health information systems, absence of unified vaccine injury compensation scheme, closed-loop听
nature of decision-making, etc.). During the COVID-19 pandemic, some gaps were addressed with ad hoc听measures. Presenters in this symposium will identify governance gaps, examine public health interventions听against the unfolding epidemiological data, and query the extent to which evidence-based decision-making听was being pursued, and the extent to which Chief Medical Officers of Health and the Public Health Agency were听empowered to serve their intended purposes.
Learning Objectives
鈥⑻鼶escribe a schema for an immunization framework that reflects responsible governance, appreciating how听
different aspects of immunization fit into the overall schema.听
鈥⑻齀dentify, compare, and summarize differences in leadership, interventions, and outcomes in different parts听of Canada, drawing on the epidemiological data available across Canada.听
鈥⑻鼸xplore why different approaches were taken in different parts of Canada, again bearing in mind the听demands of the concepts of responsible governance and responsible research and innovation.听
鈥⑻齀llustrate how clearer standards and expectations can be instantiated in a legal framework to address some听of the shortcomings identified.听
Speakers
鈥⑻齁anice Graham, Director, Technoscience and Regulation Research Unit
鈥⑻齅aya Lowe, Research Assistant, Technoscience and Regulation Research Unit
鈥⑻齊achel Parker, RIM Student, Technoscience and Regulation Research Unit
鈥⑻齂senia Kholina, Research Fellow, Technoscience and Regulation Research Unit
Moderator
鈥⑻齋hawn Harmon, Co-investigator, Technoscience and Regulation Research Unit
听
Transparency, Power and Influence in the Pharmaceutical Industry
听
On听Thursday November 4th,听the MacEachen Institute for Public Policy and Governance hosted a panel discussion on听Transparency, Power and Influence in the Pharmaceutical Industry.听
Transparency in the realm of pharmaceuticals is a deeply contested policy issue. Doctors, patients, and their allies have fought for decades to make the evidence behind many prescription drugs publicly available. And while the level of transparency has improved significantly in recent years, a number of challenges remain. It's not clear, for example, whether the evidence now on offer is actually being used to make better decisions about which drugs to prescribe. Worse, there are growing concerns that the added transparency is giving cover to parallel efforts to lower regulatory standards for drug approval.
Speakers include:
- Katherine Fierlbeck听- McCulloch Chair and Professor of Political Science at 麻豆传媒
- Janice Graham听- Professor of Medical Anthropology and Paediatrics (Infectious Diseases) at 麻豆传媒听听
- Matthew Herder听- Director of the Health Law Institute at 麻豆传媒
- Nav Persaud听- Staff Physician at St. Michael's Hospital听and Canada Research Chair in Health Justice at the University of Toronto
- Constance MacIntosh (chair)听- Acting Scholarly Director at the MacEachen Institute
听
4S Annual General Meeting听
Virtual conference
October 6-9, 2021
TRRU Team hosted a panel entitled听Evidence-based Medicine? Regulating Vaccines, Drugs and Other Health Products during COVID 19 and Beyond.听The panel is chaired by Janice Graham, Director of TRRU and Matthew Herder, TRRU Co-investigator.听
Featured presentations:听
A Critical Political Economy Perspective on the Health Product Regulatory Authorities鈥� Responses to COVID-19 Pandemic听by Ipek Iren Vural, TRRU Research Associate
Will Psychedelic-Assisted Therapies Benefit from COVID-19? Frictions, Evidence, and the Future of Regulation of Alternative Therapies听by听Agnieszka Doll, TRRU Postdoctoral Fellow听
听
Psychedelics: Past, Present, Future
Webinar series
October - December 2021
TRRU and听听co-hosted a webinar series in the Fall 2021 semester.
Featured webinars:
听by听Dr. Tehseen N Noorani (UK) on October 26, 2021听
听by听Dr. Katherine Hendy (US) on November 30, 2021
听by听Dr. Christian Elcock (France) on December 9, 2021